SCHEMBL25340003

SCHEMBL25340003

FC(F)(F)c1ccc(Oc2ccccc2-c2ccc3c(Cl)nc(Cl)nc3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.38
▸ DHFR P00374 2/20 0.37
▸ SCN9A Q15858 2/20 0.37
▸ ENPP1 P22413 1/20 0.36
▸ AR P10275 1/20 0.36
▸ F2 P00734 1/20 0.36
▸ PLG P00747 1/20 0.36
▸ PRSS1 P07477 1/20 0.36
▸ ALOX5AP P20292 2/20 0.35
▸ FEN1 P39748 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ ACP1 P24666 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ESR1 P03372 1/20 0.34
▸ CCNE2 O96020 1/20 0.34
▸ CCNE1 P24864 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25340448 0.78 TRPV1 (0.38) TRPV1LMNAHPGD
SCHEMBL29909108 0.73 C1R (0.43) KDM4ELMNA
SCHEMBL2531193 0.73 C1R (0.43) KDM4ELMNA
SCHEMBL28672016 0.72 NCOA1 (0.62) SCN9AARALDH1A1NCOA1NCOA3
SCHEMBL25429720 0.71 HSD17B10 (0.55) TRPV1SCN9AARALDH1A1
SCHEMBL25429629 0.70 TRPV1 (0.46) TRPV1SCN9AAR
SCHEMBL3992772 0.70 AR (0.48) SCN9AARNCOA1NCOA3
SCHEMBL25429460 0.70 KIF11 (0.53) SCN9AARKDM4EALDH1A1POLB
SCHEMBL25955024 0.69 TRPV1 (0.49) TRPV1SCN9AARFEN1KDM4E
SCHEMBL17412365 0.68 DHFR (0.51) DHFRKDM4ELMNAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback